日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Validation of a novel cognitive-functional outcome measure optimized for early Alzheimer's Disease: Evidence from the VIVA-MIND trial

验证一种针对早期阿尔茨海默病优化的新型认知功能结局指标:来自 VIVA-MIND 试验的证据

Duehring, Jasmin A; Jacobs, Diane M; Salmon, David P; MacKelfresh, Andrew J; Revta, Carolyn; Meyer, Antje; Schaeffer, Michael; Schell-Mader, Sylvia; Wassmann, Tanja; Wenzkowski, Christine; Feldman, Howard H; Edland, Steven D

α-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson Disease

α-突触核蛋白种子扩增检测扩增参数与前驱期帕金森病进展风险

Coughlin, David G; Shifflett, Ben; Farris, Carly M; Ma, Yihua; Galasko, Douglas; Edland, Steven D; Mollenhauer, Brit; Brumm, Michael C; Poston, Kathleen L; Marek, Kenneth; Siderowf, Andrew D; Soto, Claudio; Concha-Marambio, Luis

Implications of practice effects for the design of Alzheimer clinical trials

练习效应对阿尔茨海默病临床试验设计的影响

Duehring, Jasmin A; Jacobs, Diane M; Thomas, Michael L; Dodge, Hiroko H; Feldman, Howard H; Edland, Steven D

Enrichment for clinical trials of early AD: Combining genetic risk factors and plasma p-tau as screening instruments

早期阿尔茨海默病临床试验的富集:将遗传风险因素和血浆磷酸化tau蛋白(p-tau)作为筛选工具

Wang, Xin; Wang, Xinran; Edland, Steven D; Broce, Iris J; Dale, Anders M; Banks, Sarah J

Memory-related brain potentials for visual objects in early AD show impairment and compensatory mechanisms

早期阿尔茨海默病患者视觉对象相关的记忆脑电位显示出损伤和代偿机制。

Xia, Jiangyi; Kutas, Marta; Salmon, David P; Stoermann, Anna M; Rigatuso, Siena N; Tomaszewski Farias, Sarah E; Edland, Steven D; Brewer, James B; Olichney, John M

Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam)

一项无缝衔接的 2A 期-2B 期随机双盲安慰剂对照试验方案,旨在评估苯磷硫胺在早期阿尔茨海默病患者中的安全性和有效性(BenfoTeam)

Feldman, Howard H; Luchsinger, José A; Léger, Gabriel C; Taylor, Curtis; Jacobs, Diane M; Salmon, David P; Edland, Steven D; Messer, Karen; Revta, Carolyn; Flowers, Sarah A; Jones, Kerry S; Koulman, Albert; Yarasheski, Kevin E; Verghese, Philip B; Venkatesh, Venky; Zetterberg, Henrik; Durant, January; Lupo, Jody-Lynn; Gibson, Gary E

Exercise: Just What the Doctor Ordered, But Why? Elucidating Mechanisms for Women's Increased High-Density Lipoprotein Benefit From Exercise and for the Health ABC Study

运动:正是医生所建议的,但为什么?阐明女性从运动中获益更多高密度脂蛋白的机制以及健康ABC研究

Bernier, Rachel A; Sundermann, Erin E; Edland, Steven D; Deters, Kacie D; Shepherd, Alyx L; Clark, Alexandra L; Shiroma, Eric J; Banks, Sarah J

A simple genetic stratification method for lower cost, more expedient clinical trials in early Alzheimer's disease: A preliminary study of tau PET and cognitive outcomes

一种用于降低成本、加快早期阿尔茨海默病临床试验的简易遗传分层方法:tau PET 与认知结果的初步研究

Wang, Xin; Broce, Iris; Qiu, Yuqi; Deters, Kacie D; Fan, Chun Chieh; Dale, Anders M; Edland, Steven D; Banks, Sarah J

A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment

II 期研究旨在探索阿托莫西汀在轻度认知障碍中的神经保护作用

Levey, Allan I; Qiu, Deqiang; Zhao, Liping; Hu, William T; Duong, Duc M; Higginbotham, Lenora; Dammer, Eric B; Seyfried, Nicholas T; Wingo, Thomas S; Hales, Chadwick M; Gámez Tansey, Malú; Goldstein, David S; Abrol, Anees; Calhoun, Vince D; Goldstein, Felicia C; Hajjar, Ihab; Fagan, Anne M; Galasko, Doug; Edland, Steven D; Hanfelt, John; Lah, James J; Weinshenker, David

Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report

高质量阿尔茨海默病研究委员会(CHADS)共识报告

Jicha, Greg A; Abner, Erin L; Arnold, Steven E; Carrillo, Maria C; Dodge, Hiroko H; Edland, Steven D; Fargo, Keith N; Feldman, Howard H; Goldstein, Larry B; Hendrix, James; Peters, Ruth; Robillard, Julie M; Schneider, Lon S; Titiner, Jodi R; Weber, Christopher J